rethinkPeptides Search
Menu
Study breakdown

High Blood Sugar Triggers Pancreatic Cells to Produce the Opioid Peptide Dynorphin

In VitroPreliminary evidence
The takeaway

Pancreatic beta-cells respond to high glucose by producing and secreting dynorphin, an opioid peptide that may serve as a feedback signal in blood sugar regulation.

20 of 53 clones

Prodynorphin was by far the most commonly induced gene in glucose-stimulated beta-cells

What the researchers found

Glucose stimulation induced prodynorphin gene expression in pancreatic beta-cell lines, with dynorphin peptides being processed and secreted, suggesting a novel opioid-mediated feedback mechanism in glucose regulation.

Why it matters

The discovery that beta-cells produce opioid peptides in response to glucose reveals a previously unknown layer of blood sugar regulation that could have implications for understanding diabetes and developing new treatments.

How the study worked

In-vitro study using subtraction cloning to identify glucose-induced genes in pancreatic beta-cell lines. Dynorphin expression and secretion were confirmed with immunoassays and molecular analysis.

What this study cannot tell us

In-vitro study using cell lines, not intact pancreatic tissue. The functional role of secreted dynorphin was not determined. Cell line behavior may differ from normal beta-cells.

How to read the evidence

Preliminary evidence from an in-vitro cell line study with novel gene discovery findings that need in-vivo confirmation.

When this study was published

Published in 1998. The opioid-pancreas connection remains an active but still incompletely understood area of research.

The bigger picture

The connection between opioid peptides and blood sugar regulation is poorly understood. If dynorphin acts as a feedback signal from beta-cells, it could explain some of the complex interactions between the opioid system and metabolic health, including why opioid medications sometimes affect blood sugar.

Questions still open

  • Does dynorphin secreted by beta-cells act on nearby cells to regulate insulin release?
  • Is this opioid pathway disrupted in type 2 diabetes?
  • Could targeting dynorphin signaling offer a new approach to blood sugar management?

Common questions

What is dynorphin?
Dynorphin is a naturally occurring opioid peptide in the body. Unlike endorphins which produce feelings of pleasure, dynorphins are involved in pain modulation, stress responses, and now potentially blood sugar regulation.
What does this mean for diabetes research?
This study reveals that pancreatic cells have a built-in opioid signaling system that responds to blood sugar. If this pathway is disrupted in diabetes, it could represent both a new way to understand the disease and a potential treatment target.

Read the original research

Glucose stimulation of pancreatic beta-cell lines induces expression and secretion of dynorphin.

Endocrinology, 139(10), 4329-36

Citation

Josefsen, K; Buschard, K; Sørensen, L R; Wøllike, M; Ekman, R; Birkenbach, M. (1998). Glucose stimulation of pancreatic beta-cell lines induces expression and secretion of dynorphin.. Endocrinology, 139(10), 4329-36.